Takeda Pharmaceutical Co. (TAK)
(Real Time Quote from BATS)
$13.10 USD
-0.13 (-0.98%)
Updated Apr 25, 2024 09:54 AM ET
1-Strong Buy of 5 1
A Value F Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | 0.51 |
Last EPS Surprise | NA |
ABR | 1.50 |
Earnings ESP
|
NA |
---|---|
Current Year | 1.50 |
Next Year | 1.55 |
EPS (TTM) | 1.95 |
P/E (F1) | 8.54 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 28.10B | 26.99B |
# of Estimates | NA | NA | 2 | 2 |
High Estimate | NA | NA | 28.40B | 27.37B |
Low Estimate | NA | NA | 27.80B | 26.62B |
Year ago Sales | 7.23B | 7.71B | 30.39B | 28.10B |
Year over Year Growth Est. | NA | NA | -7.53% | -3.95% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 1.50 | 1.55 |
# of Estimates | NA | NA | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | NA | NA | 1.57 | 1.64 |
Low Estimate | NA | NA | 1.45 | 1.45 |
Year ago EPS | 0.39 | 0.55 | 2.07 | 1.50 |
Year over Year Growth Est. | NA | NA | -27.54% | 3.11% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | 0 |
Up Last 30 Days | NA | NA | 0 | 0 |
Up Last 60 Days | NA | NA | 1 | 2 |
Down Last 7 Days | NA | NA | 0 | 0 |
Down Last 30 Days | NA | NA | 0 | 0 |
Down Last 60 Days | NA | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Current | NA | NA | 1.50 | 1.55 |
7 Days Ago | NA | NA | 1.50 | 1.55 |
30 Days Ago | NA | NA | 1.50 | 1.55 |
60 Days Ago | NA | NA | 1.11 | 1.16 |
90 Days Ago | NA | NA | 0.28 | 0.38 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | 1.50 | 1.55 |
Zacks Consensus Estimate | NA | NA | 1.50 | 1.55 |
Earnings ESP | NA | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.51 | 0.50 | 0.55 | 0.39 | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more